From May 11, 2023 to June 30, 2023, the company has repurchased 5,669,900 shares, representing 1.51% for ¥7,036.46 million. With this, the company has completed the repurchase of 5,669,900 shares, representing 1.51% for ¥7,036.46 million under the buyback announced on May 11, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,648 JPY | +0.98% | +7.78% | +17.30% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.30% | 3.81B | |
+29.98% | 684B | |
+30.34% | 568B | |
-3.52% | 361B | |
+18.59% | 329B | |
+4.07% | 284B | |
+16.21% | 240B | |
+9.66% | 208B | |
-6.83% | 200B | |
+7.09% | 166B |
- Stock Market
- Equities
- 4536 Stock
- News Santen Pharmaceutical Co., Ltd.
- Tranche Update on Santen Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 11, 2023.